<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Review Article To Do or Not to Do?â€&quot;A Review of" exact="Cancer" post="Surgery Triage Guidelines in COVID-19 Pandemic http://orcid.org/0000-0001-9478-8676ShindeRajesh S.dr.rajeshinde@gmail.comdr.rajeshinde@icloud.com12NaikMekhala D.3ShindeShital"/>
 <result pre="V.5DcruzAnil K.12[1], grid.464529.80000 0004 1802 3059Department of Surgical Oncology, Gastrointestinal" exact="Cancer" post="Surgery, Apollo Hospitals, [2], grid.414537.00000 0004 1766 7856Department of"/>
 <result pre="Hospitals, [2], grid.414537.00000 0004 1766 7856Department of Surgical Oncology, Gastrointestinal" exact="Cancer" post="Surgery, Bombay Hospital Institute of Medical Sciences, [3], grid.414537.00000"/>
 <result pre="healthcare infrastructures in many affected countries. Due to overall rising" exact="cancer" post="incidence and specific concerns, a cohort of cancer patients"/>
 <result pre="overall rising cancer incidence and specific concerns, a cohort of" exact="cancer" post="patients forms a distinct subset of the population in"/>
 <result pre="remains the best line of defence in many solid organ" exact="tumours" post="especially in early stage and is potentially curative. China,"/>
 <result pre="to enter the post transitional phase of this pandemic. Deferring" exact="cancer" post="surgeries for this long period may have a direct"/>
 <result pre="may have a direct impact on the long-term outcomes of" exact="cancer" post="patients. Many surgical oncology associations across the globe have"/>
 <result pre="have come up with triage guidelines for surgical care of" exact="cancer" post="patients; however, these are based on expert opinion rather"/>
 <result pre="to review these guidelines with respect to the risk of" exact="disease" post="progression in cancer patients. In the absence of actual"/>
 <result pre="guidelines with respect to the risk of disease progression in" exact="cancer" post="patients. In the absence of actual data on cancer"/>
 <result pre="the risk of disease progression in cancer patients. In the" exact="absence of" post="actual data on cancer surgery care during this pandemic,"/>
 <result pre="in cancer patients. In the absence of actual data on" exact="cancer" post="surgery care during this pandemic, clinical decisions should be"/>
 <result pre="consideration of disease-related and patient-related factors. While some of the" exact="cancer" post="surgeries can be safely delayed for some time, how"/>
 <result pre="team appears to be the most effective way forward. Keywords" exact="Cancer" post="Surgery Triage Guidelines Introduction In the new decade, our"/>
 <result pre="pressure on healthcare facilities combined with other realities of increasing" exact="cancer" post="incidence, the need for special resources in oncology care,"/>
 <result pre="prognosis in many malignancies and semi-emergent nature and need of" exact="cancer" post="treatment, it is extremely difficult for an oncology healthcare"/>
 <result pre="an oncology healthcare personnel to decide who gets treatment for" exact="cancer" post="and who has to wait. While the oncologist makes"/>
 <result pre="between logical and philosophical decision making during this crisis. As" exact="cancer" post="surgeries involve significant healthcare resources in terms of infrastructure,"/>
 <result pre="by professional organisations like the Society of Surgical Oncology (SSO)," exact="American" post="Cancer Society (ACS), European Association of Urology (EAU), Indian"/>
 <result pre="professional organisations like the Society of Surgical Oncology (SSO), American" exact="Cancer" post="Society (ACS), European Association of Urology (EAU), Indian Association"/>
 <result pre="at places. Herein, we intend to review triage guidelines for" exact="cancer" post="surgery, laid down by these associations around the globe."/>
 <result pre="MERS epidemics on experience and implications in the field of" exact="cancer" post="surgery. The â€˜Novelâ€™ Virus The novel coronavirus (SARS-CoV-2) has"/>
 <result pre="routes. Unlike the SARS-CoV, patients of SARS-CoV-2 can transmit the" exact="infection" post="during the incubation period as well [3]. The age"/>
 <result pre="[3]. The age group with the highest risk for acquiring" exact="primary" post="and secondary cases of infection is 50â€&quot;65Â years (most"/>
 <result pre="age group with the highest risk for acquiring primary and" exact="secondary" post="cases of infection is 50â€&quot;65Â years (most cancers are"/>
 <result pre="the highest risk for acquiring primary and secondary cases of" exact="infection" post="is 50â€&quot;65Â years (most cancers are found in the"/>
 <result pre="ICU care and ventilatory requirement. Symptoms common to most coronavirus" exact="infections" post="are fever, chills, generalized myalgia, drowsiness, cough, shortness of"/>
 <result pre="abdominal pain, nausea, vomiting and diarrhoea. The median duration of" exact="viral" post="shedding is about 20Â days and longest known to"/>
 <result pre="time to death being 18.5Â days [4]. Sepsis, followed by" exact="respiratory" post="failure, adult respiratory distress syndrome (ARDS), heart failure, acute"/>
 <result pre="death being 18.5Â days [4]. Sepsis, followed by respiratory failure," exact="adult" post="respiratory distress syndrome (ARDS), heart failure, acute kidney injury,"/>
 <result pre="being 18.5Â days [4]. Sepsis, followed by respiratory failure, adult" exact="respiratory" post="distress syndrome (ARDS), heart failure, acute kidney injury, shock"/>
 <result pre="days [4]. Sepsis, followed by respiratory failure, adult respiratory distress" exact="syndrome" post="(ARDS), heart failure, acute kidney injury, shock and secondary"/>
 <result pre="Sepsis, followed by respiratory failure, adult respiratory distress syndrome (ARDS)," exact="heart" post="failure, acute kidney injury, shock and secondary infections (including"/>
 <result pre="by respiratory failure, adult respiratory distress syndrome (ARDS), heart failure," exact="acute" post="kidney injury, shock and secondary infections (including ventilator-associated pneumonia)"/>
 <result pre="respiratory failure, adult respiratory distress syndrome (ARDS), heart failure, acute" exact="kidney injury," post="shock and secondary infections (including ventilator-associated pneumonia) are the"/>
 <result pre="distress syndrome (ARDS), heart failure, acute kidney injury, shock and" exact="secondary" post="infections (including ventilator-associated pneumonia) are the common complications with"/>
 <result pre="syndrome (ARDS), heart failure, acute kidney injury, shock and secondary" exact="infections" post="(including ventilator-associated pneumonia) are the common complications with severe"/>
 <result pre="infections (including ventilator-associated pneumonia) are the common complications with severe" exact="infections" post="[4]. The virus can be isolated from oropharyngeal and"/>
 <result pre="infections [4]. The virus can be isolated from oropharyngeal and" exact="respiratory" post="secretions and also in stool samples of affected individuals."/>
 <result pre="urine [5]. The World Health Organization (WHO) and Centre for" exact="Disease" post="Control and Prevention (CDC) recommend RT-PCR for laboratory diagnosis"/>
 <result pre="to the GLOBOCAN 2018, globally, there were 18.1 million new" exact="cancer" post="cases and 9.6 million cancer deaths in 2018 with"/>
 <result pre="there were 18.1 million new cancer cases and 9.6 million" exact="cancer" post="deaths in 2018 with a speculated increasing trend in"/>
 <result pre="2018 with a speculated increasing trend in overall incidence [9]." exact="Cancer" post="patients are at heightened risk for infection owing to"/>
 <result pre="overall incidence [9]. Cancer patients are at heightened risk for" exact="infection" post="owing to suppressed immunity due to the malignancy per"/>
 <result pre="to suppressed immunity due to the malignancy per se and" exact="secondary" post="to the effect of chemotherapy, radiotherapy and surgery. Also,"/>
 <result pre="to intensive care units, overall poor prognosis and death in" exact="cancer" post="patients with COVID-19 infection. A particular concern for a"/>
 <result pre="cancer patients with COVID-19 infection. A particular concern for a" exact="cancer" post="surgeon is to weigh the risk of deferring cancer"/>
 <result pre="a cancer surgeon is to weigh the risk of deferring" exact="cancer" post="surgery versus the risk of COVID-19 exposure and infection"/>
 <result pre="deferring cancer surgery versus the risk of COVID-19 exposure and" exact="infection" post="to patients as well as health care providers. Disruptions"/>
 <result pre="outbreak mitigation strategies like social distancing and prudent utilization of" exact="limited" post="health resources also need consideration in this regard [10,"/>
 <result pre="health resources also need consideration in this regard [10, 11]." exact="Cancer" post="Surgery in COVID-19 Outbreak Cancer surgeries utilise substantial resources"/>
 <result pre="in this regard [10, 11]. Cancer Surgery in COVID-19 Outbreak" exact="Cancer" post="surgeries utilise substantial resources in a hospital including diagnostic"/>
 <result pre="data suggesting transmission of SARS CoV-2 by transfusion. However, the" exact="American" post="Association of Blood Banks and European Center for Disease"/>
 <result pre="of SARS CoV-2 by transfusion. However, the American Association of" exact="Blood" post="Banks and European Center for Disease prevention and Control"/>
 <result pre="the American Association of Blood Banks and European Center for" exact="Disease" post="prevention and Control (ECDC) have suggested deferral of blood"/>
 <result pre="recommended [12, 13]. Published Chinese reports on the outcomes of" exact="cancer" post="patients infected with COVID-19 indicated a 3.5 times higher"/>
 <result pre="ventilation or ICU admission or dying compared with patients without" exact="cancer" post="[10]. Thus altogether, subjecting a cancer patient to surgery"/>
 <result pre="compared with patients without cancer [10]. Thus altogether, subjecting a" exact="cancer" post="patient to surgery has its own risks to the"/>
 <result pre="the patient and burdening the hospital resources. However, delaying the" exact="cancer" post="surgeries have other implications like an increased extent of"/>
 <result pre="like an increased extent of surgery in the event of" exact="cancer" post="progression, increased perioperative morbidity/mortality and also missing a chance"/>
 <result pre="and also missing a chance of offering cure due to" exact="disease" post="spread caused by waiting. These facts cannot be overseen,"/>
 <result pre="spread caused by waiting. These facts cannot be overseen, also," exact="cancer" post="is a bigger problem than COVID-19 from patientâ€™s perspective."/>
 <result pre="impact of time to treatment initiation or delaying surgeries on" exact="cancer" post="survival [14â€&quot;27]. Keeping these concerns in mind, some guidelines"/>
 <result pre="1 Various studies addressing the impact of waiting time/TTI on" exact="cancer" post="survival/prognosis Author, year [Ref] No of patients Malignancy Time"/>
 <result pre="days does not affect survival in patients with stage II/III" exact="gastric cancer." post="Visser et al. 2016 [16] 351 Oesophagus 8Â weeks"/>
 <result pre="on DFS or OS. Bleicher et al. 2015 [17] 94,544" exact="Breast" post="â€‰30Â days Significant difference in DFS and OS in"/>
 <result pre="â€‰30Â days Significant difference in DFS and OS in early" exact="breast cancer." post="Shin et al. 2013 [18] 7529 Colorectal, breast, thyroid,"/>
 <result pre="12Â weeksâ€™ delay is associated with increased mortality in colorectal," exact="breast" post="but not thyroid/lung cancers. Fossati et al. 2017 [19]"/>
 <result pre="[20] 3,672,561 Pancreas, lung, breast, kidney, colorectal Median TTI-27Â days" exact="Increased" post="TTI is associated with absolute increased risk of mortality"/>
 <result pre="pancreas cancers. Murphy et al. 2016 [21] 51,655 Head neck" exact="Increased" post="mortality beyond 46â€&quot;52Â days, detrimental beyond 60Â days. Dolly"/>
 <result pre="in recurrence/disease free survival Froehner et al. 2016 [24] 1" exact="Kidney" post="30Â days Rapid increase in the level of tumour"/>
 <result pre="187 UTUC â€‰3Â months Delay to surgery is associated with" exact="disease" post="progression but not with mortality or recurrence. Baudin et"/>
 <result pre="with mortality or recurrence. Baudin et al. 2015 [26] â€&quot;" exact="Adrenal" post="â€&quot; ACC progresses rapidly and delay may decrease resectability"/>
 <result pre="NACT neoadjuvant chemotherapy, DFS disease-free survival, OS overall survival, PTC" exact="papillary" post="thyroid cancer, UTUC upper urothelial tract urothelial carcinoma, MIBC"/>
 <result pre="neoadjuvant chemotherapy, DFS disease-free survival, OS overall survival, PTC papillary" exact="thyroid cancer," post="UTUC upper urothelial tract urothelial carcinoma, MIBC muscle invasive"/>
 <result pre="disease-free survival, OS overall survival, PTC papillary thyroid cancer, UTUC" exact="upper" post="urothelial tract urothelial carcinoma, MIBC muscle invasive bladder cancer,"/>
 <result pre="papillary thyroid cancer, UTUC upper urothelial tract urothelial carcinoma, MIBC" exact="muscle" post="invasive bladder cancer, HCC hepatocellular carcinoma, ACC adrenocortical carcinoma"/>
 <result pre="cancer, UTUC upper urothelial tract urothelial carcinoma, MIBC muscle invasive" exact="bladder cancer," post="HCC hepatocellular carcinoma, ACC adrenocortical carcinoma Table 2 Priority"/>
 <result pre="urothelial tract urothelial carcinoma, MIBC muscle invasive bladder cancer, HCC" exact="hepatocellular carcinoma," post="ACC adrenocortical carcinoma Table 2 Priority surgery recommendations based"/>
 <result pre="carcinoma, MIBC muscle invasive bladder cancer, HCC hepatocellular carcinoma, ACC" exact="adrenocortical carcinoma" post="Table 2 Priority surgery recommendations based on different guidelines"/>
 <result pre="MIBC muscle invasive bladder cancer, HCC hepatocellular carcinoma, ACC adrenocortical" exact="carcinoma" post="Table 2 Priority surgery recommendations based on different guidelines"/>
 <result pre="Malignancy ACS guidelines* [28] SSO guidelines [29] IASO guidelines [30]" exact="Breast" post="Post NACT IDC, HER2-positive cases, Tumours with discordant biopsy"/>
 <result pre="Breast Post NACT IDC, HER2-positive cases, Tumours with discordant biopsy" exact="recurrent" post="tumours. Progressive disease on NACT Angiosarcoma Malignant phyllodes tumour."/>
 <result pre="NACT IDC, HER2-positive cases, Tumours with discordant biopsy recurrent tumours." exact="Progressive" post="disease on NACT Angiosarcoma Malignant phyllodes tumour. Poor responders"/>
 <result pre="IDC, HER2-positive cases, Tumours with discordant biopsy recurrent tumours. Progressive" exact="disease" post="on NACT Angiosarcoma Malignant phyllodes tumour. Poor responders to"/>
 <result pre="with discordant biopsy recurrent tumours. Progressive disease on NACT Angiosarcoma" exact="Malignant" post="phyllodes tumour. Poor responders to NACT Malignant phyllodes Sarcomas"/>
 <result pre="on NACT Angiosarcoma Malignant phyllodes tumour. Poor responders to NACT" exact="Malignant" post="phyllodes Sarcomas Patients where systemic therapy cannot be offered."/>
 <result pre="Angiosarcoma Malignant phyllodes tumour. Poor responders to NACT Malignant phyllodes" exact="Sarcomas" post="Patients where systemic therapy cannot be offered. Thoracic Oesophageal"/>
 <result pre="tumour. Poor responders to NACT Malignant phyllodes Sarcomas Patients where" exact="systemic" post="therapy cannot be offered. Thoracic Oesophageal cancer Lung cancer"/>
 <result pre="Malignant phyllodes Sarcomas Patients where systemic therapy cannot be offered." exact="Thoracic" post="Oesophageal cancer Lung cancer &amp;gt;â€‰2Â cm, post NACT High-grade"/>
 <result pre="Sarcomas Patients where systemic therapy cannot be offered. Thoracic Oesophageal" exact="cancer" post="Lung cancer &amp;gt;â€‰2Â cm, post NACT High-grade chest wall"/>
 <result pre="Patients where systemic therapy cannot be offered. Thoracic Oesophageal cancer" exact="Lung cancer" post="&amp;gt;â€‰2Â cm, post NACT High-grade chest wall tumours Symptomatic"/>
 <result pre="where systemic therapy cannot be offered. Thoracic Oesophageal cancer Lung" exact="cancer" post="&amp;gt;â€‰2Â cm, post NACT High-grade chest wall tumours Symptomatic"/>
 <result pre="Thoracic Oesophageal cancer Lung cancer &amp;gt;â€‰2Â cm, post NACT High-grade" exact="chest" post="wall tumours Symptomatic mediastinal tumours Staging mediastinoscopy â€&quot; Lung"/>
 <result pre="cancer Lung cancer &amp;gt;â€‰2Â cm, post NACT High-grade chest wall" exact="tumours" post="Symptomatic mediastinal tumours Staging mediastinoscopy â€&quot; Lung cancer Post"/>
 <result pre="&amp;gt;â€‰2Â cm, post NACT High-grade chest wall tumours Symptomatic mediastinal" exact="tumours" post="Staging mediastinoscopy â€&quot; Lung cancer Post NACT oesophageal cancer"/>
 <result pre="High-grade chest wall tumours Symptomatic mediastinal tumours Staging mediastinoscopy â€&quot;" exact="Lung cancer" post="Post NACT oesophageal cancer HPB â€&quot; Curative intent stomach"/>
 <result pre="chest wall tumours Symptomatic mediastinal tumours Staging mediastinoscopy â€&quot; Lung" exact="cancer" post="Post NACT oesophageal cancer HPB â€&quot; Curative intent stomach"/>
 <result pre="Symptomatic mediastinal tumours Staging mediastinoscopy â€&quot; Lung cancer Post NACT" exact="oesophageal cancer" post="HPB â€&quot; Curative intent stomach pancreas, periampullary and duodenal"/>
 <result pre="mediastinal tumours Staging mediastinoscopy â€&quot; Lung cancer Post NACT oesophageal" exact="cancer" post="HPB â€&quot; Curative intent stomach pancreas, periampullary and duodenal"/>
 <result pre="cancer HPB â€&quot; Curative intent stomach pancreas, periampullary and duodenal" exact="cancer" post="cases Pancreas/periampullary cancer Gall bladder cancer Post NACT stomach"/>
 <result pre="Curative intent stomach pancreas, periampullary and duodenal cancer cases Pancreas/periampullary" exact="cancer" post="Gall bladder cancer Post NACT stomach cancer Colorectal Colonic"/>
 <result pre="stomach pancreas, periampullary and duodenal cancer cases Pancreas/periampullary cancer Gall" exact="bladder cancer" post="Post NACT stomach cancer Colorectal Colonic cancer Nearly obstructing/bleeding"/>
 <result pre="pancreas, periampullary and duodenal cancer cases Pancreas/periampullary cancer Gall bladder" exact="cancer" post="Post NACT stomach cancer Colorectal Colonic cancer Nearly obstructing/bleeding"/>
 <result pre="duodenal cancer cases Pancreas/periampullary cancer Gall bladder cancer Post NACT" exact="stomach cancer" post="Colorectal Colonic cancer Nearly obstructing/bleeding tumours Poor responders to"/>
 <result pre="cancer cases Pancreas/periampullary cancer Gall bladder cancer Post NACT stomach" exact="cancer" post="Colorectal Colonic cancer Nearly obstructing/bleeding tumours Poor responders to"/>
 <result pre="Pancreas/periampullary cancer Gall bladder cancer Post NACT stomach cancer Colorectal" exact="Colonic" post="cancer Nearly obstructing/bleeding tumours Poor responders to NACTRT Curative"/>
 <result pre="cancer Gall bladder cancer Post NACT stomach cancer Colorectal Colonic" exact="cancer" post="Nearly obstructing/bleeding tumours Poor responders to NACTRT Curative intent"/>
 <result pre="cancer Post NACT stomach cancer Colorectal Colonic cancer Nearly obstructing/bleeding" exact="tumours" post="Poor responders to NACTRT Curative intent colonic cancer cases"/>
 <result pre="Nearly obstructing/bleeding tumours Poor responders to NACTRT Curative intent colonic" exact="cancer" post="cases Colonic cancer Gynaecological Ovarian cancer Endometrial cancer Cervical"/>
 <result pre="tumours Poor responders to NACTRT Curative intent colonic cancer cases" exact="Colonic" post="cancer Gynaecological Ovarian cancer Endometrial cancer Cervical cancer Gestational"/>
 <result pre="Poor responders to NACTRT Curative intent colonic cancer cases Colonic" exact="cancer" post="Gynaecological Ovarian cancer Endometrial cancer Cervical cancer Gestational trophoblastic"/>
 <result pre="NACTRT Curative intent colonic cancer cases Colonic cancer Gynaecological Ovarian" exact="cancer" post="Endometrial cancer Cervical cancer Gestational trophoblastic tumours â€&quot; Early"/>
 <result pre="Curative intent colonic cancer cases Colonic cancer Gynaecological Ovarian cancer" exact="Endometrial" post="cancer Cervical cancer Gestational trophoblastic tumours â€&quot; Early cervical"/>
 <result pre="intent colonic cancer cases Colonic cancer Gynaecological Ovarian cancer Endometrial" exact="cancer" post="Cervical cancer Gestational trophoblastic tumours â€&quot; Early cervical cancer"/>
 <result pre="cancer cases Colonic cancer Gynaecological Ovarian cancer Endometrial cancer Cervical" exact="cancer" post="Gestational trophoblastic tumours â€&quot; Early cervical cancer Soft tissue"/>
 <result pre="cancer Gynaecological Ovarian cancer Endometrial cancer Cervical cancer Gestational trophoblastic" exact="tumours" post="â€&quot; Early cervical cancer Soft tissue â€&quot; Non-metastatic STS"/>
 <result pre="cancer Endometrial cancer Cervical cancer Gestational trophoblastic tumours â€&quot; Early" exact="cervical cancer" post="Soft tissue â€&quot; Non-metastatic STS High-grade sarcomas Urological â€&quot;"/>
 <result pre="Endometrial cancer Cervical cancer Gestational trophoblastic tumours â€&quot; Early cervical" exact="cancer" post="Soft tissue â€&quot; Non-metastatic STS High-grade sarcomas Urological â€&quot;"/>
 <result pre="Early cervical cancer Soft tissue â€&quot; Non-metastatic STS High-grade sarcomas" exact="Urological" post="â€&quot; â€&quot; Orchiectomy for testicular cancer Head Neck â€&quot;"/>
 <result pre="â€&quot; Non-metastatic STS High-grade sarcomas Urological â€&quot; â€&quot; Orchiectomy for" exact="testicular cancer" post="Head Neck â€&quot; â€&quot; T1 and T2 lesions which"/>
 <result pre="Non-metastatic STS High-grade sarcomas Urological â€&quot; â€&quot; Orchiectomy for testicular" exact="cancer" post="Head Neck â€&quot; â€&quot; T1 and T2 lesions which"/>
 <result pre="be operated with minimal hospitalisation, aggressive thyroid cancers and refractory" exact="hyperparathyroidism" post="FHNO guidelines for head neck malignancies EAU Guidelines for"/>
 <result pre="Day care surgery and surgery for early lesions MIBC Testicular" exact="cancer" post="(orchiectomy) Post NACT RPLND cT3+ renal cancer High-grade UTUC"/>
 <result pre="early lesions MIBC Testicular cancer (orchiectomy) Post NACT RPLND cT3+" exact="renal cancer" post="High-grade UTUC ACCâ€‰&amp;gt;â€‰6Â cm Penile/urethral cancer ACS American College"/>
 <result pre="lesions MIBC Testicular cancer (orchiectomy) Post NACT RPLND cT3+ renal" exact="cancer" post="High-grade UTUC ACCâ€‰&amp;gt;â€‰6Â cm Penile/urethral cancer ACS American College"/>
 <result pre="NACT RPLND cT3+ renal cancer High-grade UTUC ACCâ€‰&amp;gt;â€‰6Â cm Penile/urethral" exact="cancer" post="ACS American College of Surgeons, SSO Society of Surgical"/>
 <result pre="cT3+ renal cancer High-grade UTUC ACCâ€‰&amp;gt;â€‰6Â cm Penile/urethral cancer ACS" exact="American" post="College of Surgeons, SSO Society of Surgical Oncology, IASO"/>
 <result pre="European Association of Urology, HPB hepato-pancreato-biliary, NACT neoadjuvant chemotherapy, IDC" exact="infiltrating" post="ductal carcinoma, NACTRT neoadjuvant chemoradiation, STS soft tissue sarcoma,"/>
 <result pre="Association of Urology, HPB hepato-pancreato-biliary, NACT neoadjuvant chemotherapy, IDC infiltrating" exact="ductal carcinoma," post="NACTRT neoadjuvant chemoradiation, STS soft tissue sarcoma, MIBC muscle"/>
 <result pre="neoadjuvant chemotherapy, IDC infiltrating ductal carcinoma, NACTRT neoadjuvant chemoradiation, STS" exact="soft tissue sarcoma," post="MIBC muscle invasive bladder cancer, RPLND retroperitoneal lymph node"/>
 <result pre="ductal carcinoma, NACTRT neoadjuvant chemoradiation, STS soft tissue sarcoma, MIBC" exact="muscle" post="invasive bladder cancer, RPLND retroperitoneal lymph node dissection, UTUC"/>
 <result pre="NACTRT neoadjuvant chemoradiation, STS soft tissue sarcoma, MIBC muscle invasive" exact="bladder cancer," post="RPLND retroperitoneal lymph node dissection, UTUC upper tract urothelial"/>
 <result pre="muscle invasive bladder cancer, RPLND retroperitoneal lymph node dissection, UTUC" exact="upper" post="tract urothelial carcinoma, ACC adrenocortical carcinoma *Phase 1 recommendations"/>
 <result pre="retroperitoneal lymph node dissection, UTUC upper tract urothelial carcinoma, ACC" exact="adrenocortical carcinoma" post="*Phase 1 recommendations where hospital resources are not exhausted,"/>
 <result pre="lymph node dissection, UTUC upper tract urothelial carcinoma, ACC adrenocortical" exact="carcinoma" post="*Phase 1 recommendations where hospital resources are not exhausted,"/>
 <result pre="a significant risk and due precautionary measures are needed. The" exact="American" post="Association of Anaesthetists has provided excellent guidelines to follow"/>
 <result pre="anaesthesia wherever feasible, with added advantage of less effect on" exact="pulmonary" post="function as compared to general anaesthesia [31â€&quot;36]. Considering the"/>
 <result pre="it is prudent to defer the non-emergent surgical interventions. However," exact="cancer" post="surgeries cannot truly be considered as non-emergent interventions as"/>
 <result pre="as non-emergent interventions as there is a real risk of" exact="disease" post="progression during the waiting period. Individual Organ System Considerations"/>
 <result pre="been shown to be susceptible to SAR-CoV producing a sustainable" exact="infection" post="which persists after multiple passages. Intestinal biopsies from infected"/>
 <result pre="SAR-CoV producing a sustainable infection which persists after multiple passages." exact="Intestinal" post="biopsies from infected patients have demonstrated viral particles on"/>
 <result pre="after multiple passages. Intestinal biopsies from infected patients have demonstrated" exact="viral" post="particles on electron microscopy without any lytic effects or"/>
 <result pre="that clearly require emergency intervention like obstruction, perforation and massive" exact="bleeding" post="obviously cannot be deferred. Hu et al. [38], Yu"/>
 <result pre="malignancies during this pandemic and recommended stage-based treatment strategies. The" exact="American" post="College of Surgeons [28] and Society of Surgical Oncology"/>
 <result pre="based on expert opinion rather than any strong evidence. As" exact="cancer" post="surgeons, one has to be aware about the prevention"/>
 <result pre="possible in advanced gastrointestinal cancers. Obstructing growths of gastroesophageal junction" exact="or colon" post="without signs of peritonitis should be offered endoscopic stents"/>
 <result pre="Obstructing growths of gastroesophageal junction or colon without signs of" exact="peritonitis" post="should be offered endoscopic stents wherever feasible. For bleeding"/>
 <result pre="of peritonitis should be offered endoscopic stents wherever feasible. For" exact="bleeding" post="tumours, Transcatheter arterial embolization is an option if facilities"/>
 <result pre="[29]. Pre-admission screening of every patient to rule out asymptomatic" exact="infection" post="and RT-PCR panel with chest CT scan for patients"/>
 <result pre="patient to rule out asymptomatic infection and RT-PCR panel with" exact="chest" post="CT scan for patients with fever (&amp;gt;â€‰37.3Â Â°C), travel"/>
 <result pre="Â°C), travel history and positive contact history is recommended for" exact="gastrointestinal cancer" post="patients due for surgery. Extra precautionary measures should be"/>
 <result pre="travel history and positive contact history is recommended for gastrointestinal" exact="cancer" post="patients due for surgery. Extra precautionary measures should be"/>
 <result pre="be taken for medical staff involved in the surgical procedures." exact="Local" post="governing authorities should be informed if one has to"/>
 <result pre="surgeries; however, the measure to contain the aerosol dissemination during" exact="pneumoperitoneum" post="has to be dealt with care [40, 41]. Thoracic"/>
 <result pre="during pneumoperitoneum has to be dealt with care [40, 41]." exact="Thoracic" post="Cancers This cohort represents patients with a higher risk"/>
 <result pre="cohort represents patients with a higher risk for deterioration of" exact="pulmonary" post="function secondary to existing lung diseases, pneumonitis due to"/>
 <result pre="patients with a higher risk for deterioration of pulmonary function" exact="secondary" post="to existing lung diseases, pneumonitis due to other infections,"/>
 <result pre="higher risk for deterioration of pulmonary function secondary to existing" exact="lung diseases," post="pneumonitis due to other infections, radiation pneumonitis, immune checkpoint"/>
 <result pre="pneumonitis due to other infections, radiation pneumonitis, immune checkpoint inhibitor-associated" exact="pneumonia" post="and tumour progression all which can mask an underlying"/>
 <result pre="infection. CT imaging is essential for the diagnosis of SARS-CoV-2" exact="infection" post="in the absence of microbiological tests and the CT"/>
 <result pre="is essential for the diagnosis of SARS-CoV-2 infection in the" exact="absence of" post="microbiological tests and the CT picture might be confusing"/>
 <result pre="out COVID-19. Smoking, one of the commonest risk factors in" exact="lung cancer," post="has not been independently shown to affect the mortality"/>
 <result pre="shown to affect the mortality in SARS-CoV-2 patient; however, pre-existing" exact="chronic" post="obstructive lung disease is associated with increased mortality [4]."/>
 <result pre="to affect the mortality in SARS-CoV-2 patient; however, pre-existing chronic" exact="obstructive lung disease" post="is associated with increased mortality [4]. Perforated oesophageal malignancies,"/>
 <result pre="affect the mortality in SARS-CoV-2 patient; however, pre-existing chronic obstructive" exact="lung disease" post="is associated with increased mortality [4]. Perforated oesophageal malignancies,"/>
 <result pre="the mortality in SARS-CoV-2 patient; however, pre-existing chronic obstructive lung" exact="disease" post="is associated with increased mortality [4]. Perforated oesophageal malignancies,"/>
 <result pre="threatened airways, anastomotic leaks, bleeding, post-operative complications like hemothorax, and" exact="empyema" post="need immediate intervention and need to be taken to"/>
 <result pre="reported post-operative mortality in one out of two patients with" exact="lung cancer," post="who were detected SARS-CoV-2-positive after surgery. Xin et al."/>
 <result pre="al. [44] have reported specific recommendations for the management of" exact="lung cancer" post="in the COVID-19 epidemic, but these articles are published"/>
 <result pre="[44] have reported specific recommendations for the management of lung" exact="cancer" post="in the COVID-19 epidemic, but these articles are published"/>
 <result pre="exposure even with simple clinical examination. Elective surgery of the" exact="upper" post="airways requiring mandatory post-operative assisted mechanical ventilation, elective tracheostomies"/>
 <result pre="is currently no literature on experience from COVID-19 in head" exact="and neck" post="malignancies, and there is a lack of clear recommendations"/>
 <result pre="a lack of clear recommendations on triage in these cases." exact="Urological" post="Cancers Reports so far have failed to demonstrate shedding"/>
 <result pre="have failed to demonstrate shedding of SARS-CoV-2 in urine [5]." exact="Prostate cancer" post="and most renal malignancies have slow doubling times, and"/>
 <result pre="failed to demonstrate shedding of SARS-CoV-2 in urine [5]. Prostate" exact="cancer" post="and most renal malignancies have slow doubling times, and"/>
 <result pre="lymph node dissections for post chemotherapy testicular cancers, orchidectomy for" exact="testicular cancer" post="and surgeries for clinically obstructing urethral malignancies should be"/>
 <result pre="node dissections for post chemotherapy testicular cancers, orchidectomy for testicular" exact="cancer" post="and surgeries for clinically obstructing urethral malignancies should be"/>
 <result pre="[14]. Breast, Soft Tissue and Gynaecological Cancers During the crisis," exact="breast cancer" post="surgery for early lesions and suspected benign pathology should"/>
 <result pre="Breast, Soft Tissue and Gynaecological Cancers During the crisis, breast" exact="cancer" post="surgery for early lesions and suspected benign pathology should"/>
 <result pre="the crisis, breast cancer surgery for early lesions and suspected" exact="benign" post="pathology should be postponed, and those who have finished"/>
 <result pre="an additional 2â€&quot;3Â weeks on case-to-case basis. Those with progressive" exact="disease" post="on systemic therapy, angiosarcoma and malignant phyllode tumours should"/>
 <result pre="2â€&quot;3Â weeks on case-to-case basis. Those with progressive disease on" exact="systemic" post="therapy, angiosarcoma and malignant phyllode tumours should be offered"/>
 <result pre="on case-to-case basis. Those with progressive disease on systemic therapy," exact="angiosarcoma" post="and malignant phyllode tumours should be offered surgery on"/>
 <result pre="basis. Those with progressive disease on systemic therapy, angiosarcoma and" exact="malignant" post="phyllode tumours should be offered surgery on a priority"/>
 <result pre="with progressive disease on systemic therapy, angiosarcoma and malignant phyllode" exact="tumours" post="should be offered surgery on a priority basis. Most"/>
 <result pre="offered surgery on a priority basis. Most surgeries for endocrine" exact="tumours" post="can be postponed, unless those with impending airway threat,"/>
 <result pre="tumours can be postponed, unless those with impending airway threat," exact="pheochromocytoma" post="and functional neuroendocrine tumours refractory to medical management. Gynaecological"/>
 <result pre="postponed, unless those with impending airway threat, pheochromocytoma and functional" exact="neuroendocrine tumours" post="refractory to medical management. Gynaecological malignancies can be aggressive"/>
 <result pre="unless those with impending airway threat, pheochromocytoma and functional neuroendocrine" exact="tumours" post="refractory to medical management. Gynaecological malignancies can be aggressive"/>
 <result pre="most guidelines recommended to go ahead with surgery wherever feasible." exact="Infections" post="including joints and impending pathological fractures including peri-prosthetic fractures,"/>
 <result pre="extremity sarcomas in the radiation or chemotherapy window and aggressive" exact="benign" post="tumours like giant cell tumours should be offered surgical"/>
 <result pre="sarcomas in the radiation or chemotherapy window and aggressive benign" exact="tumours" post="like giant cell tumours should be offered surgical interventions"/>
 <result pre="or chemotherapy window and aggressive benign tumours like giant cell" exact="tumours" post="should be offered surgical interventions as and when required"/>
 <result pre="as and when required [28â€&quot;30, 45]. To summarise, in the" exact="absence of" post="actual data on cancer surgery care during this pandemic,"/>
 <result pre="45]. To summarise, in the absence of actual data on" exact="cancer" post="surgery care during this pandemic, clinical decisions should be"/>
 <result pre="consideration of disease-related and patient-related factors. While some of the" exact="cancer" post="surgeries can be safely delayed for some time, how"/>
 <result pre="likely to have an adverse impact on a number of" exact="cancer" post="patients due to the inevitable delay caused in their"/>
 <result pre="should be boosted in anticipation, to combat illnesses such as" exact="cancer" post="during these natural calamities. Publisherâ€™s Note Springer Nature remains"/>
 <result pre="Managing epidemics: key facts about major deadly diseases. https://www.who.int/emergencies/diseases/managing-epidemics/en/ 3.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJGuoQSongTHeJYenHLPeirisMWuJSARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patientsN Engl"/>
 <result pre="facts about major deadly diseases. https://www.who.int/emergencies/diseases/managing-epidemics/en/ 3.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJGuoQSongTHeJYenHLPeirisMWuJSARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patientsN Engl J Med2020382121177117910.1056/NEJMc200173732074444 4.ZhouFYuTDuRet"/>
 <result pre="about major deadly diseases. https://www.who.int/emergencies/diseases/managing-epidemics/en/ 3.ZouLRuanFHuangMLiangLHuangHHongZYuJKangMSongYXiaJGuoQSongTHeJYenHLPeirisMWuJSARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patientsN Engl J Med2020382121177117910.1056/NEJMc200173732074444 4.ZhouFYuTDuRet al.Clinical"/>
 <result pre="Med2020382121177117910.1056/NEJMc200173732074444 4.ZhouFYuTDuRet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="by nucleic acid amplification testsInt J Infect Dis20209326426710.1016/j.ijid.2020.02.05032114193 6.Centers for" exact="Disease" post="Control and Prevention Division of Viral Diseases. CDC 2019-novel"/>
 <result pre="Infect Dis20209326426710.1016/j.ijid.2020.02.05032114193 6.Centers for Disease Control and Prevention Division of" exact="Viral" post="Diseases. CDC 2019-novel coronavirus (2019-nCoV) Real-time RT-PCR diagnostic panel."/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov2020611610.1038/s41421-020-0156-032194981 9.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates"/>
 <result pre="is effective in inhibiting SARS-CoV-2 infection in vitroCell Discov2020611610.1038/s41421-020-0156-032194981 9.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal" exact="cancer" post="statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide"/>
 <result pre="incidence and mortality worldwide for 36 cancers in 185 countriesCA" exact="Cancer" post="J Clin201868639442410.3322/caac.2149230207593 10.LiangWGuanWChenRWangWLiJXuKLiCAiQLuWLiangHLiSHeJCancer patients in SARS-CoV-2 infection: a nationwide"/>
 <result pre="11.Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG," exact="Fisher" post="RI (2020) A war on two fronts: cancer care"/>
 <result pre="Uzzo RG, Fisher RI (2020) A war on two fronts:" exact="cancer" post="care in the time of COVID-19. Ann Intern Med."/>
 <result pre="Za Zhi20201000E013 13.Chang L, Yan Y, Wang L (2020) Coronavirus" exact="disease" post="2019: coronaviruses and blood safety. Transfus Med Rev. 10.1016/j.tmrv.2020.02.003"/>
 <result pre="patients with esophageal cancerAnn Surg Oncol20162382679268910.1245/s10434-016-5191-627012988 17.BleicherRJRuthKSigurdsonERBeckJRRossEWongYNPatelSABoraasMChangEITophamNSEglestonBLTime to surgery and" exact="breast cancer" post="survival in the United StatesJAMA Oncol20162333033910.1001/jamaoncol.2015.450826659430 18.ShinDWChoJKimSYGuallarEHwangSSChoBLOhJHJungKWSeoHGParkJHDelay to curative"/>
 <result pre="with esophageal cancerAnn Surg Oncol20162382679268910.1245/s10434-016-5191-627012988 17.BleicherRJRuthKSigurdsonERBeckJRRossEWongYNPatelSABoraasMChangEITophamNSEglestonBLTime to surgery and breast" exact="cancer" post="survival in the United StatesJAMA Oncol20162333033910.1001/jamaoncol.2015.450826659430 18.ShinDWChoJKimSYGuallarEHwangSSChoBLOhJHJungKWSeoHGParkJHDelay to curative"/>
 <result pre="is associated with increased mortality in patients with colorectal and" exact="breast cancer" post="but not lung or thyroid cancerAnn Surg Oncol20132082468247610.1245/s10434-013-2957-y23529782 19.FossatiNRossiMSCucchiaraVet"/>
 <result pre="associated with increased mortality in patients with colorectal and breast" exact="cancer" post="but not lung or thyroid cancerAnn Surg Oncol20132082468247610.1245/s10434-013-2957-y23529782 19.FossatiNRossiMSCucchiaraVet"/>
 <result pre="cancerAnn Surg Oncol20132082468247610.1245/s10434-013-2957-y23529782 19.FossatiNRossiMSCucchiaraVet al.Evaluating the effect of time from" exact="prostate cancer" post="diagnosis to radical prostatectomy on cancer control: can surgery"/>
 <result pre="Surg Oncol20132082468247610.1245/s10434-013-2957-y23529782 19.FossatiNRossiMSCucchiaraVet al.Evaluating the effect of time from prostate" exact="cancer" post="diagnosis to radical prostatectomy on cancer control: can surgery"/>
 <result pre="of time from prostate cancer diagnosis to radical prostatectomy on" exact="cancer" post="control: can surgery be postponed safely?Urol Oncol2017354150.e9150.e1510.1016/j.urolonc.2016.11.010 20.KhoranaAATullioKElsonPPennellNAGrobmyerSRKaladyMFRaymondDAbrahamJKleinEAWalshRMMonteleoneEEWeiWHobbsBBolwellBJTime to"/>
 <result pre="control: can surgery be postponed safely?Urol Oncol2017354150.e9150.e1510.1016/j.urolonc.2016.11.010 20.KhoranaAATullioKElsonPPennellNAGrobmyerSRKaladyMFRaymondDAbrahamJKleinEAWalshRMMonteleoneEEWeiWHobbsBBolwellBJTime to initial" exact="cancer" post="treatment in the United States and association with survival"/>
 <result pre="impact of increasing time to treatment initiation for patients with" exact="head and neck cancer" post="in the United StatesJ Clin Oncol201634216917810.1200/JCO.2015.61.590626628469 22.DollyDMihaiARimelBJFoggLRotmenschJGuirguisAYordanEDewdneySA delay from"/>
 <result pre="of increasing time to treatment initiation for patients with head" exact="and neck" post="cancer in the United StatesJ Clin Oncol201634216917810.1200/JCO.2015.61.590626628469 22.DollyDMihaiARimelBJFoggLRotmenschJGuirguisAYordanEDewdneySA delay"/>
 <result pre="time to treatment initiation for patients with head and neck" exact="cancer" post="in the United StatesJ Clin Oncol201634216917810.1200/JCO.2015.61.590626628469 22.DollyDMihaiARimelBJFoggLRotmenschJGuirguisAYordanEDewdneySA delay from"/>
 <result pre="Oncol201663110.3389/fonc.2016.0003126904507 23.JeonMJKimWGKwonHKimMParkSOhHSHanMSungTYChungKWHongSJKimTYShongYKKimWBClinical outcomes after delayed thyroid surgery in patients with" exact="papillary" post="thyroid micro carcinomaEur J Endocrinol20171771253110.1530/EJE-17-016028432268 24.FroehnerMHeberlingUZastrowSTomaMWirthMPGrowth of a level"/>
 <result pre="carcinomaEur J Endocrinol20171771253110.1530/EJE-17-016028432268 24.FroehnerMHeberlingUZastrowSTomaMWirthMPGrowth of a level III vena cava" exact="tumor" post="thrombus within 1 monthUrology.201690e1e210.1016/j.urology.2015.12.04326772645 25.WaldertMKarakiewiczPIRamanJDRemziMIsbarnHLotanYCapitanioUBensalahKMarbergerMJShariatSFA delay in radical nephroureterectomy"/>
 <result pre="delay in radical nephroureterectomy can lead to upstagingBJU Int2010105681281710.1111/j.1464-410X.2009.08821.x19732052 26.BaudinEEndocrine" exact="tumor" post="board of Gustave Roussy. Adrenocortical carcinomaEndocrinol Metab Clin N"/>
 <result pre="lead to upstagingBJU Int2010105681281710.1111/j.1464-410X.2009.08821.x19732052 26.BaudinEEndocrine tumor board of Gustave Roussy." exact="Adrenocortical" post="carcinomaEndocrinol Metab Clin N Am201544241143410.1016/j.ecl.2015.03.001 27.KabirTSynNRamkumarMYeoEYJTeoJYKohYXLeeSYCheowPCChowPKHChungAYFOoiLLChanCYGohBKPEffect of surgical delay"/>
 <result pre="delay on survival outcomes in patients undergoing curative resection for" exact="primary" post="hepatocellular carcinoma: inverse probability of treatment weighting using propensity"/>
 <result pre="during a COVID â€�19 epidemicAnaesthesia202075682382410.1111/anae.1505332221974 33.SorbelloM.Elâ€�BoghdadlyK.Di GiacintoI.CataldoR.EspositoC.FalcettaS.MerliG.CorteseG.CorsoR. M.BressanF.PintaudiS.GreifR.DonatiA.PetriniF.The Italian coronavirus" exact="disease" post="2019 outbreak: recommendations from clinical practiceAnaesthesia202075672473210.1111/anae.1504932221973 34.CookT. M.Elâ€�BoghdadlyK.McGuireB.McNarryA. F.PatelA.HiggsA.Consensus"/>
 <result pre="(2020) Perioperative COVID-19 defense: an evidence-based approach for optimization of" exact="infection" post="control and operating room management. Anesth Analg. 10.1213/ANE.0000000000004829 36.Lie"/>
 <result pre="COVID-19 pandemic. Can J Anaesth. 10.1007/s12630-020-01637-0 37.ChanPKScollab: To KFLoAWIet al.Persistent" exact="infection" post="of SARS coronavirus in colonic cells in vitroJ Med"/>
 <result pre="colonic cells in vitroJ Med Virol20047411710.1002/jmv.2013815258961 38.HuXHNiuWBZhangJFet al.Treatment strategies for" exact="colorectal cancer" post="patients in tumor hospitals under the background of corona"/>
 <result pre="cells in vitroJ Med Virol20047411710.1002/jmv.2013815258961 38.HuXHNiuWBZhangJFet al.Treatment strategies for colorectal" exact="cancer" post="patients in tumor hospitals under the background of corona"/>
 <result pre="Med Virol20047411710.1002/jmv.2013815258961 38.HuXHNiuWBZhangJFet al.Treatment strategies for colorectal cancer patients in" exact="tumor" post="hospitals under the background of corona virus disease 2019Zhonghua"/>
 <result pre="patients in tumor hospitals under the background of corona virus" exact="disease" post="2019Zhonghua Wei Chang Wai Ke Za Zhi202023320120832192294 39.YuGYLouZZhangWSeveral suggestions"/>
 <result pre="Chang Wai Ke Za Zhi202023320120832192294 39.YuGYLouZZhangWSeveral suggestions of operation for" exact="colorectal cancer" post="under the outbreak of corona virus disease 2019 in"/>
 <result pre="Wai Ke Za Zhi202023320120832192294 39.YuGYLouZZhangWSeveral suggestions of operation for colorectal" exact="cancer" post="under the outbreak of corona virus disease 2019 in"/>
 <result pre="operation for colorectal cancer under the outbreak of corona virus" exact="disease" post="2019 in ChinaZhonghua Wei Chang Wai Ke Za Zhi202023320821132192295"/>
 <result pre="Chang Wai Ke Za Zhi202023320821132192295 40.LuoYZhongMStandardized diagnosis and treatment of" exact="colorectal cancer" post="during the outbreak of corona virus disease 2019 in"/>
 <result pre="Wai Ke Za Zhi202023320821132192295 40.LuoYZhongMStandardized diagnosis and treatment of colorectal" exact="cancer" post="during the outbreak of corona virus disease 2019 in"/>
 <result pre="treatment of colorectal cancer during the outbreak of corona virus" exact="disease" post="2019 in Renji hospitalZhonghua Wei Chang Wai Ke Za"/>
 <result pre="Wei Chang Wai Ke Za Zhi202023321121632192296 41.ChenYHPengJSTreatment strategy for gastrointestinal" exact="tumor" post="under the outbreak of novel coronavirus pneumonia in ChinaZhonghua"/>
 <result pre="strategy for gastrointestinal tumor under the outbreak of novel coronavirus" exact="pneumonia" post="in ChinaZhonghua Wei Chang Wai Ke Za Zhi2020232IIV32074786 42.TianSufangHuWeidongNiuLiLiuHuanXuHaiboXiaoShu-YuanPulmonary"/>
 <result pre="Za Zhi2020232IIV32074786 42.TianSufangHuWeidongNiuLiLiuHuanXuHaiboXiaoShu-YuanPulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19)" exact="Pneumonia" post="in Two Patients With Lung CancerJournal of Thoracic Oncology202015570070410.1016/j.jtho.2020.02.01032114094"/>
 <result pre="Coronavirus (COVID-19) Pneumonia in Two Patients With Lung CancerJournal of" exact="Thoracic" post="Oncology202015570070410.1016/j.jtho.2020.02.01032114094 43.LiXLiuMZhaoQLiuRZhangHDongMXuSZhaoHWeiSSongZChenGChenJPreliminary recommendations for lung surgery during 2019 novel"/>
 <result pre="Oncology202015570070410.1016/j.jtho.2020.02.01032114094 43.LiXLiuMZhaoQLiuRZhangHDongMXuSZhaoHWeiSSongZChenGChenJPreliminary recommendations for lung surgery during 2019 novel coronavirus" exact="disease" post="(COVID-19) epidemic periodZhongguo Fei Ai Za Zhi.202023313313532077440 44.XuYLiuHHuKWangMClinical management"/>
 <result pre="(COVID-19) epidemic periodZhongguo Fei Ai Za Zhi.202023313313532077440 44.XuYLiuHHuKWangMClinical management of" exact="lung cancer" post="patients during the outbreak of 2019 novel coronavirus disease"/>
 <result pre="epidemic periodZhongguo Fei Ai Za Zhi.202023313313532077440 44.XuYLiuHHuKWangMClinical management of lung" exact="cancer" post="patients during the outbreak of 2019 novel coronavirus disease"/>
 <result pre="lung cancer patients during the outbreak of 2019 novel coronavirus" exact="disease" post="(COVID-19)Zhongguo Fei Ai Za Zhi202023313614132077441 45.JiangZFLiJBTen hot issues on"/>
 <result pre="Za Zhi202023313614132077441 45.JiangZFLiJBTen hot issues on diagnosis and treatment of" exact="breast cancer" post="under the outbreak of novel coronavirus pneumoniaZhonghua Yi Xue"/>
 <result pre="Zhi202023313614132077441 45.JiangZFLiJBTen hot issues on diagnosis and treatment of breast" exact="cancer" post="under the outbreak of novel coronavirus pneumoniaZhonghua Yi Xue"/>
</results>
